封面
市場調查報告書
商品編碼
1812425

細胞冷凍介質市場:按產品類型、按細胞類型、按冷凍保護劑類型、按應用、按配方、按最終用戶、按地區

Cell Freezing Media Market, By Product Type, By Cell Type, By Cryoprotectant Type, By Application, By Formulation, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

細胞冷凍培養基市場規模預計在 2025 年達到 19.2 億美元,預計到 2032 年將達到 36.8 億美元,2025 年至 2032 年的複合年成長率為 9.73%。

報告範圍 報告詳細資訊
基準年 2024 2025年的市場規模 19.2億美元
效能數據 2020年至2024年 預測期 2020年至2024年
預測期:2025-2032年複合年成長率: 9.73% 2032年的價值預測 36.8億美元

全球細胞凍存介質市場是生物技術和製藥產業的重要組成部分,也是低溫儲存過程中維持細胞活力的重要保存解決方案。細胞凍存介質,也稱為低溫保存介質,是一種專門設計的配方,旨在保護細胞結構免受凍融過程中冰晶形成和滲透壓的影響。

這些培養基通常含有冷凍保護劑,例如二甲基亞碸(DMSO)、甘油和各種促進細胞在超低溫下存活的蛋白質。該市場提供多種產品類型,包括含血清和無血清配方,每種配方均針對特定細胞類型和研究應用量身定做。隨著細胞和基因治療研究、再生醫學和生物銀行活動的擴展,對高品質細胞冷凍培養基的需求顯著成長。該市場服務於各種各樣的最終用戶,包括製藥公司、生物技術公司、研究機構和細胞庫,他們需要可靠的儲存解決方案來長期保存珍貴的生物樣本和治療細胞,同時確保解凍後細胞的最佳恢復和功能。

市場動態

全球細胞凍存介質市場受到多個關鍵因素的支撐,這些因素推動了其強勁的成長軌跡。主要驅動力是細胞和基因治療研究的快速發展,在這些研究中,維持細胞在儲存期間的活力對於成功治療至關重要。慢性病和遺傳疾病的日益普及推動了再生醫學的研究活動,對有效的冷凍保存解決方案產生了巨大的需求。此外,全球生物樣本庫數量的不斷增加,加上幹細胞研究舉措的不斷擴展,也對市場成長做出了重大貢獻。個人化醫療方法的興起以及對患者特異性細胞長期儲存的需求進一步擴大了需求。

然而,該市場也面臨一些限制,例如優質細胞凍存培養基配方高成本,這可能會對小型研究機構和新興生物技術公司造成負擔。凍存培養基中使用動物性成分的監管複雜性也帶來了額外的挑戰,需要進行廣泛的驗證過程。此外,品管要求以及針對不同應用的標準化通訊協定也限制了市場准入。

儘管有這些局限性,但無血清培養基和化學成分確定的培養基配方的技術進步為解決安全和監管問題提供了重要機會。在組織工程、器官移植研究和新型治療方法開發中不斷擴展的應用,帶來了豐厚的成長機會。此外,新興經濟體對醫療基礎設施的投資不斷增加,以及自動化冷凍保存系統的日益普及,也為創新細胞冷凍培養基解決方案創造了新的市場機會。

本次調查的主要特點

  • 本報告對全球細胞冷凍培養基市場進行了詳細分析,並以 2024 年為基準年,給出了預測期(2025-2032 年)的市場規模(十億美元)和年複合成長率(CAGR%)。
  • 它揭示了各個領域的潛在商機,並解釋了該市場有吸引力的投資提案矩陣。
  • 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
  • 它根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數概述了全球細胞冷凍培養基市場的主要企業。
  • 本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
  • 全球細胞冷凍培養基市場報告涉及該行業的各個相關人員,例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
  • 相關人員可以透過分析全球細胞冷凍培養基市場所使用的各種策略矩陣更輕鬆地做出決策。

目錄

第 1 章:調查目標與先決條件

  • 調查目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要

第3章:市場動態、法規與趨勢分析

  • 市場動態
  • 驅動程式
  • 抑制因素
  • 機會
  • 影響分析
  • 主要進展
  • 監管情景
  • 產品發布/核准
  • PEST分析
  • 波特分析
  • 併購場景
  • 產業趨勢

4. 2020-2032 年全球細胞冷凍培養基市場(依產品類型)

  • 含血清的冷凍培養基
  • 無血清冷凍培養基
  • 無蛋白冷凍培養基
  • 化學成分確定的冷凍培養基

5. 全球細胞冷凍培養基市場(依細胞型),2020-2032

  • 哺乳動物細胞冷凍培養基
  • 幹細胞冷凍培養基
  • 原代細胞冷凍培養基
  • 昆蟲細胞冷凍培養基
  • 微生物細胞冷凍培養基

6. 2020 年至 2032 年全球細胞冷凍介質市場(以冷凍保護劑類型)

  • 含DMSO的培養基
  • 無DMSO培養基
  • 甘油基培養基

7. 全球細胞冷凍培養基市場(依應用分類),2020-2032

  • 幹細胞保存
  • 組織保存
  • 精子冷凍
  • 卵子/胚胎冷凍
  • 再生醫學

8. 全球細胞冷凍培養基市場(依配方),2020-2032

  • RTU處方
  • 客製化/研究級配方

9. 全球細胞冷凍培養基市場(依最終用戶分類),2020-2032

  • 製藥和生物技術公司
  • 醫院和診斷實驗室
  • 細胞庫和生物檢體資料庫
  • 合約研究組織(CRO)
  • 其他(學術、研究機構等)

第 10 章。 2020-2032 年按地區分類的全球細胞冷凍培養基市場

  • 北美洲
      • 美國
      • 加拿大
  • 拉丁美洲
      • 巴西
      • 阿根廷
      • 墨西哥
      • 其他拉丁美洲
  • 歐洲
      • 德國
      • 英國
      • 西班牙
      • 法國
      • 義大利
      • 俄羅斯
      • 其他歐洲國家
  • 亞太地區
      • 中國
      • 印度
      • 日本
      • 澳洲
      • 韓國
      • ASEAN
      • 其他亞太地區
  • 中東
      • 海灣合作理事會國家
      • 以色列
      • 其他中東地區
  • 非洲
      • 南非
      • 北非
      • 中部非洲

第11章 競爭格局

  • Thermo Fisher Scientific Inc.
  • Cytiva(Danaher Corporation)
  • Merck KGaA(Sigma-Aldrich)
  • Lonza Group AG
  • STEMCELL Technologies Inc.
  • BioLife Solutions Inc.
  • Corning Incorporated
  • HiMedia Laboratories Pvt. Ltd.
  • FUJIFILM Irvine Scientific Inc.
  • MP Biomedicals LLC
  • AMSBIO(AMS Biotechnology)
  • Nacalai Tesque Inc.
  • Cell Applications Inc.
  • Miltenyi Biotec BV and Co. KG
  • Sartorius AG

第 12 章分析師建議

  • 機會
  • 分析師觀點
  • Coherent Opportunity Map

第13章參考文獻與調查方法

  • 參考
  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI8434

Cell Freezing Media Market is estimated to be valued at USD 1.92 Bn in 2025 and is expected to reach USD 3.68 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.73% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 1.92 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 9.73% 2032 Value Projection: USD 3.68 Bn

The global cell freezing media market represents a critical component of the biotechnology and pharmaceutical industries, serving as an essential preservation solution for maintaining cell viability during cryogenic storage processes. Cell freezing media, also known as cryopreservation media, are specialized formulations designed to protect cellular structures from ice crystal formation and osmotic stress during the freezing and thawing processes.

These media typically contain cryoprotectants such as Dimethyl Sulfoxide (DMSO), glycerol, and various proteins that facilitate cellular survival at ultra-low temperatures. The market encompasses various product types including serum-containing and serum-free formulations, each tailored to specific cell types and research applications. With the expanding scope of cell and gene therapy research, regenerative medicine, and biobanking activities, the demand for high-quality cell freezing media has witnessed substantial growth. The market serves diverse end-users including pharmaceutical companies, biotechnology firms, research institutions, and cell banks, all requiring reliable preservation solutions to maintain valuable biological samples and therapeutic cells for extended periods while ensuring optimal recovery rates and cellular functionality upon thawing.

Market Dynamics

The global cell freezing media market is propelled by several key drivers that collectively fuel its robust growth trajectory. The primary driver stems from the exponential expansion of cell and gene therapy research, where maintaining cell viability during storage is paramount for successful therapeutic outcomes. The increasing prevalence of chronic diseases and genetic disorders has intensified research activities in regenerative medicine, creating substantial demand for effective cryopreservation solutions. Additionally, the growing number of biobanks worldwide, coupled with expanding stem cell research initiatives, significantly contributes to market growth. The rise in personalized medicine approaches and the need for long-term storage of patient-specific cells further amplifies demand.

However, the market faces certain restraints including the high costs associated with premium cell freezing media formulations, which can burden smaller research institutions and emerging biotechnology companies. Regulatory complexities surrounding the use of animal-derived components in freezing media pose additional challenges, necessitating extensive validation processes. Quality control requirements and the need for standardized protocols across different applications can also limit market accessibility.

Despite these constraints, significant opportunities emerge from technological advancements in serum-free and chemically-defined media formulations, addressing safety and regulatory concerns. The expanding applications in tissue engineering, organ transplantation research, and the development of novel therapeutic modalities present lucrative growth avenues. Furthermore, increasing investments in healthcare infrastructure in emerging economies and the growing adoption of automated cryopreservation systems create new market opportunities for innovative cell freezing media solutions.

Key Features of the Study

  • This report provides in-depth analysis of the global cell freezing media market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global cell freezing media market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Cytiva (Danaher Corporation), Merck KGaA (Sigma-Aldrich), Lonza Group AG, STEMCELL Technologies Inc., BioLife Solutions Inc., Corning Incorporated, HiMedia Laboratories Pvt. Ltd., FUJIFILM Irvine Scientific Inc., MP Biomedicals LLC, AMSBIO (AMS Biotechnology), Nacalai Tesque Inc., Cell Applications Inc., Miltenyi Biotec B.V. and Co. KG, Sartorius AG
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global cell freezing media market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell freezing media market

Market Segmentation

  • Product Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Serum-containing Freezing Media
    • Serum-free Freezing Media
    • Protein-free Freezing Media
    • Chemically-defined Freezing Media
  • Cell Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Mammalian Cell Freezing Media
    • Stem Cell Freezing Media
    • Primary Cell Freezing Media
    • Insect Cell Freezing Media
    • Microbial Cell Freezing Media
  • Cryoprotectant Type Insights (Revenue, USD Bn, 2020 - 2032)
    • DMSO-containing Media
    • DMSO-free Media
    • Glycerol-based Media
  • Application Insights (Revenue, USD Bn, 2020 - 2032)
    • Stem Cell Preservation
    • Tissue Preservation
    • Sperm Freezing
    • Oocyte and Embryo Freezing
    • Regenerative Medicine
  • Formulation Insights (Revenue, USD Bn, 2020 - 2032)
    • Ready-to-use Formulations
    • Custom/Research-grade Formulations
  • End User Insights (Revenue, USD Bn, 2020 - 2032)
    • Pharmaceutical and Biotechnology Companies
    • Hospitals and Diagnostic Laboratories
    • Cell Banks and Biorepositories
    • Contract Research Organizations (CROs)
    • Others (Academic and Research Institutes, etc.)
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Thermo Fisher Scientific Inc.
    • Cytiva (Danaher Corporation)
    • Merck KGaA (Sigma-Aldrich)
    • Lonza Group AG
    • STEMCELL Technologies Inc.
    • BioLife Solutions Inc.
    • Corning Incorporated
    • HiMedia Laboratories Pvt. Ltd.
    • FUJIFILM Irvine Scientific Inc.
    • MP Biomedicals LLC
    • AMSBIO (AMS Biotechnology)
    • Nacalai Tesque Inc.
    • Cell Applications Inc.
    • Miltenyi Biotec B.V. and Co. KG
    • Sartorius AG

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Cell Freezing Media Market, By Product Type
    • Global Cell Freezing Media Market, By Cell Type
    • Global Cell Freezing Media Market, By Cryoprotectant Type
    • Global Cell Freezing Media Market, By Application
    • Global Cell Freezing Media Market, By Formulation
    • Global Cell Freezing Media Market, By End User
    • Global Cell Freezing Media Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Cell Freezing Media Market, By Product Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Serum-containing Freezing Media
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Serum-free Freezing Media
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Protein-free Freezing Media
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Chemically-defined Freezing Media
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Cell Freezing Media Market, By Cell Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Mammalian Cell Freezing Media
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Stem Cell Freezing Media
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Primary Cell Freezing Media
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Insect Cell Freezing Media
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Microbial Cell Freezing Media
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Cell Freezing Media Market, By Cryoprotectant Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • DMSO-containing Media
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • DMSO-free Media
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Glycerol-based Media
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Cell Freezing Media Market, By Application, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Stem Cell Preservation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Tissue Preservation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Sperm Freezing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Oocyte and Embryo Freezing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Regenerative Medicine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Cell Freezing Media Market, By Formulation, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Ready-to-use Formulations
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Custom/Research-grade Formulations
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Cell Freezing Media Market, By End User, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Pharmaceutical and Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Hospitals and Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Cell Banks and Biorepositories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Contract Research Organizations (CROs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others (Academic and Research Institutes, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Cell Freezing Media Market, By Region, 2020 - 2032, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Cell Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Cryoprotectant Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Cell Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Cryoprotectant Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Cell Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Cryoprotectant Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Cell Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Cryoprotectant Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Cell Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Cryoprotectant Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Cell Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Cryoprotectant Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

11. Competitive Landscape

  • Thermo Fisher Scientific Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cytiva (Danaher Corporation)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck KGaA (Sigma-Aldrich)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Lonza Group AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • STEMCELL Technologies Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • BioLife Solutions Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Corning Incorporated
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • HiMedia Laboratories Pvt. Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • FUJIFILM Irvine Scientific Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • MP Biomedicals LLC
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • AMSBIO (AMS Biotechnology)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Nacalai Tesque Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cell Applications Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Miltenyi Biotec B.V. and Co. KG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sartorius AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

12. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

13. References and Research Methodology

  • References
  • Research Methodology
  • About Us